Following arthroplasty of the knee, the patient's perception of improvement in symptoms is fundamental to the assessment of outcome. Better clinical outcome may offset the inferior survival observed for some types of implant. By examining linked National Joint Registry (NJR) and patient-reported outcome measures (PROMs) data, we aimed to compare PROMs collected at a minimum of six months post-operatively for total (TKR: n = 23 393) and unicondylar knee replacements (UKR: n = 505). Improvements in knee-specific (Oxford knee score, OKS) and generic (EuroQol, EQ-5D) scores were compared and adjusted for case-mix differences using multiple regression. Whereas the improvements in the OKS and EQ-5D were significantly greater for TKR than for UKR, once adjustments were made for case-mix differences and pre-operative score, the improvements in the two scores were not significantly different. The adjusted mean differences in the improvement of OKS and EQ-5D were 0.0 (95% confidence interval (CI) -0.9 to 0.9; p = 0.96) and 0.009 (95% CI -0.034 to 0.015; p = 0.37), respectively. We found no difference in the improvement of either knee-specific or general health outcomes between TKR and UKR in a large cohort of registry patients. With concerns about significantly higher revision rates for UKR observed in worldwide registries, we question the widespread use of an arthroplasty that does not confer a significant benefit in clinical outcome.
1
Specialist centres have reported better functional outcomes, equivalent implant survival and easier revision for UKR than for total knee replacement (TKR), even at 10 to 15 years. [2] [3] [4] [5] Whereas some non-specialist centres have been able to replicate this success, [6] [7] [8] others have not. [9] [10] [11] Also, several national registries have reported inferior survival for UKR than for TKR when matched for age and gender. 1, [12] [13] [14] [15] It has been suggested that this may be partly explained by differential revision thresholds for these types of implant, 16 but nevertheless the data represent a reflection of the reality of current practice. Independent analysis of the use of UKR in the United Kingdom NHS has suggested it to be cheaper, functionally superior and underused. 17 However, this contrasts with the Finnish registry, where inferior survival and the cost of revision has meant that UKR was not cost-effective at a national level. 15 Following any operation, the patient's perception of the outcome is fundamental. Greater improvements in patient-reported outcome measures (PROMs) following UKR when compared with TKR may allay some of the concerns about implant survival and the costeffectiveness of the former. Therefore we examined PROMs data linked to the NJR in order to compare specific and generic outcomes and complication rates for UKR and TKR. We also investigated which patient and surgical variables influence improvements in PROMs, thereby allowing us to create a model to adjust for the observed differences in casemix between UKR and TKR. We could then establish whether there was a difference in PROMs that could be attributed to the type of implant. The null hypothesis was that once adjustments had been made for variations in baseline characteristics there would be no difference between UKR and TKR in the mean change from baseline for PROM scores or complication rates at a minimum of six months post-operatively.
Patients and Methods
Applications were made to access both the PROMs and corresponding NJR records for patients who had undergone primary knee arthroplasty since April 2008. By linking the two datasets at the patient level we were able to combine the PROMs with the demographic and operative details in the NJR. Patients were excluded if either the questionnaire or its date of completion was missing; if the follow-up was less than six months; or if they had undergone procedures other than UKR or TKR. This left a total of 23 898 NJR-PROMs linked primary arthroplasties (23 393 TKR, 505 UKR) for analysis (Fig. 1 ). Questionnaires were collected at medians of 15 days pre-operatively (15 days (0 to 90) and 12 days (0 to 90) for TKR and UKR, respectively) and 199 days post-operatively (199 days (180 to 365) and 199 days (180 to 349) for TKR and UKR, respectively).
The PROMs questionnaires for knee arthroplasty contain specific, validated assessments of knee function, namely the Oxford knee score (OKS), 18 and assessments of general wellbeing, namely the EuroQol-5D (EQ-5D), 19 which is a generic measure of health used for clinical and economic appraisal. It is common to all PROMs questionnaires and allows comparison within and between procedures. The OKS (0, worst; 48, best) relates to the procedure under investigation and can only be compared within that procedure. Additional post-operative information relating to patient-reported complications (wound problems, bleeding, urinary infection, allergic reaction, readmission, reoperation) is collected. The questions on complications are derived from the patient's experience-of-surgery questionnaire, which has previously been used to audit complications after day-case surgery. 20 As part of the pre-operative questionnaire, patients are asked about comorbidities, general health and self-reported disability, which can be used Cohort used for analysis n = 23 898
Exclusions due to patients not yet reaching threshold for 6 month PROMs follow-up n = 10 633
Exclusions due to missing PROMs questionnaires n = 8043 One questionnaire missing n = 7886 Both questionnaires missing n = 157
Exclusions due to missing dates of completion for the PROMs questionnaires n = 2676 Date missing on one questionnaire n = 2605 Dates missing for both questionnaires n = 71
Exclusions due to inadequate follow up n = 5195 Pre-operative PROMs completed > 90 days before surgery Post-operative PROMS completed < 180 days or > 365 days after surgery Exclusions due to the procedure not being a primary unicondylar or total knee replacement n = 1113 (patellofemoral replacement or revision surgery) Fig. 1 Flowchart describing the preparation of the dataset for analysis.
to understand the differences in health status among patients presenting for different operations.
The patient demographics for the TKR and UKR groups are shown in Table I . There were marked differences between the groups, with the UKR patients being younger and in better overall health. The UKR group also had a greater proportion of males, operations performed in independent centres, and operations performed by a consultant. In order to ensure that the data we were analysing represented the population undergoing primary knee arthroplasty, the study cohort was compared with the demographic details for national TKR and UKR patients in the NJR Eighth Annual Report (Table I) . This demonstrated that the cohorts were comparable for both groups, and we therefore felt that the patients recording PROMs were representative of the wider population of patients undergoing these two operations. Statistical analysis. The factorial NJR data on grade of lead surgeon, type of hospital and indication for surgery were grouped into their most frequently occurring levels of Consultant, NHS hospital and osteoarthritis, respectively, versus all other levels combined. This was done because each of these factors had one overwhelming level and a number of others for which the numbers were relatively small. This approach also meant that the factors could each be treated as covariates during analysis. Initial comparisons of the demographics and PROMs for the TKR and UKR groups were undertaken using a combination of independentsamples t-tests for continuous data, Fisher's and chisquared tests for categorical data, and ordinal logistic regression for ordinal data. As with the PROMs feasibility pilot, 21 we aimed to compare the two types of arthroplasty according to change in disease-specific PROM (OKS), change in generic PROM (EQ-5D index), presented as both the EQ-5D index value and in the tabular format recommended by the EuroQol group, 19 and proportion of patients reporting any of the six recorded complications.
In order to allow a meaningful comparison between UKR and TKR it was important to account for differences in case mix (patients' characteristics), which could be potential confounding factors in any comparative analysis. We therefore sought to determine the case-mix variables that explained the largest proportion of the variance in each of the outcomes of interest. This was achieved using multiple regression (OKS/EQ-5D) and logistic regression (complications) modelling. The models included all patient characteristics and clinical factors collected by the NJR and pre-operative PROMs questionnaire. The variables included, with the details of how they were recorded, are listed in Table II . In order to help limit the effects of multiple testing and ensure we had a model containing only the most important variables, the final models included only those variables that were significant at a p-value of < 0.001. Whereas body mass index (BMI) was significant (p < 0.001) in the models relating to the change in OKS and EQ-5D, there were sufficient concerns about the quantity of missing data (approximately 40%) and the possibility for recording bias that we excluded it from the model. Also, within the models BMI was only responsible for a small amount of the explained variance, and was correlated with other more influential variables responsible for a greater proportion of the explained variance in the model (pre-operative OKS: r = -0.22, p < 0.001; Age: r = -0.25, p < 0.001). Modelling was performed by stepwise reduction from the full model, and all final models were checked for adequacy of their residuals. Using these models we were able to 'adjust' the observed PROMs taking into account the inherent background variability associated with each of the two types of arthroplasty. Adjustment was performed by comparing the differences in final model residuals for TKR and UKR. This effectively compares the differences in the residual variation associated with the two groups after the variation associated with the factors included in the final model has been accounted for. PROMs data for both the 'unadjusted' (direct reporting of the PROMs without accounting for case-mix variation) and 'adjusted' (PROMs adjusted for case-mix variation) outcomes for TKR and UKR were reported, so that the effects of adjustment for each outcome can be observed.
For the smaller UKR group, power calculations were undertaken to assess the size of effect that could be confidently detected, based on the sample size and standard deviations of the change in OKS and EQ-5D index. With a power of 80% and significance of p = 0.01 we could detect a difference in the change in OKS of 2.1 points and a difference in the change in EQ-5D index of 0.07 points. These differences were below the effect sizes felt to be clinically significant for these two scores. However, owing to the effects of multiple statistical testing, borderline p-values between 0.01 and 0.05 should be interpreted with caution, and therefore we advise using a p-value of < 0.01 to indicate statistical significance.
As no patient-sensitive data were involved the analysis was performed as a service evaluation without the need for formal ethical approval. Statistical analysis was performed using Genstat 10th Edition (Lawes Agricultural Trust, Hemel Hempstead, United Kingdom) and Minitab version 16 (Minitab Inc., Coventry, United Kingdom). Figure 2 . Unadjusted PROMs. There were significant post-operative improvements in knee-specific and generic PROMs for both types of arthroplasty (Tables III and IV) . Analysis of the unadjusted PROMs showed that the improvements in OKS and EQ-5D were greater following TKR than following UKR, although the post-operative PROMs were better after UKR (Table III) . These differences were largely explained by the differences in the pre-operative baseline scores for both groups, emphasising the need to correct for these differences when analysing these data. The unadjusted overall rates of complications were similar for the two groups, although there was a trend for lower rates of wound complications (p = 0.02), lower rates of readmission (p = 0.02) and a higher rate of patients requiring further surgery (p = 0.02, all Fisher's exact test) in the UKR group (Table V) . Development of risk-adjustment model. Regression models were generated for each of the response variables of interest (change in OKS, change in EQ-5D index, and rate of complications). Initial univariate analysis of the effect of the type of arthroplasty on the PROMs outcomes showed there was a relationship for the change in OKS (p = 0.007) and EQ-5D index (p = 0.02) but not the rate of complications (p = 0.12, all linear regression). This is consistent with the previous analysis. However, once all other variables were entered into the model the effect of type of arthroplasty diminished and was no longer significant.
Results

Graphs of the improvement in the OKS and EQ-5D index are shown in
The variables included in the final models are shown in Table VI . For the change in OKS and EQ-5D index, the Histograms showing the distribution of change in a) Oxford knee score (OKS) and b) EuroQol (EQ-5D) index for all primary arthroplasties (median follow-up 6.6 months (6 to 12)). most important variable in the models was the relevant preoperative score. In both cases there was a greater change in score as the pre-operative score decreased, so that patients who were worst to begin with had the best improvement. This highlights the influence of the baseline score on the ability to improve post-operatively, and the possible ceiling effects of these two scores, whereby patients with better pre-operative scores are unable to improve to the same extent as those with poorer scores, owing to the inability of these scores to detect top-end differences. This further emphasises the importance of appropriate adjustment when comparing PROMs. Two variables appeared in all three models: pre-operative general health and anxiety level. For these variables, along with pre-operative disability, number of comorbidities and depression, the observed relationship with the response variable was for smaller improvements in score with greater levels of anxiety, depression, pre-operative disability and worsening pre-operative general health.
Adjusted PROMS. Adjustment was done using multiple linear regression for the change in OKS and EQ-5D models and logistic regression for the complication rate model. After adjustment, the mean difference between the change in OKS for the TKR and UKR groups was 0.0 (95% confidence interval (CI) -0.9 to 0.9; p = 0.96). The adjusted change in EQ-5D index was greater for UKR than for TKR (mean difference of 0.09 (95% CI -0.015 to 0.034; p = 0.37) ( Table VII) . The odds of developing a complication were also similar for the two groups (odds ratio (OR) TKR versus UKR = 1.17 (95% CI 0.92 to 1.37); p = 0.24).
Discussion
This study is the first to examine linked NJR-PROMs data in order to compare clinical outcomes after UKR and TKR. We showed that, whereas unadjusted improvements in PROMs were greater for TKR than for UKR, once adjustments had been made for differences in case mix, there were no statistically significant or clinically important differences in the improvements in knee-specific outcomes, generic outcomes or complication rates. The strength of the study is the large number of patients with linked NJR-PROMs data, which allowed us to adjust for a large number of potentially confounding factors. Albeit useful in this context, the models we developed are unlikely to be suitable for comparisons within each of the implant groups owing to differences in other variables, such as bearing type, meniscal design, patellar resurfacing or use of navigation, which were not appropriate in this analysis. The observation that our results changed after risk adjustment emphasises the importance of case mix when comparing PROMs. 21 Although we attempted to account for many of the potential confounding factors, one for which we were unable to correct was the severity and distribution of pre-operative arthritis. We could not therefore select a comparable cohort of patients with medial compartment osteoarthritis suitable for either UKR or TKR. However, the models we developed include variables such as age, preoperative OKS and general health, which correlated with severity of disease and therefore acted as surrogate markers for it. This allowed us to adjust for differences in the severity of disease between the groups and gain the best possible representative comparison of these arthroplasties from registry data. We also concede that some of the included variables, such as patient-reported 'general health', are nonvalidated and somewhat arbitrary. Interestingly, however, this variable was more significant than other 'established' markers of general health, such as ASA grade and number of comorbidities.
The minimum follow-up for this study was six months, with a median of 6.6 months. Whereas most functional improvement after knee arthroplasty occurs within six months, further small improvements can be expected up to a year post-operatively. 22 This analysis therefore does not consider the differences that may appear with continued follow-up. Finally, the numbers of UKR in this study were smaller than might be expected, given that UKRs represent approximately 8% of all primary knee arthroplasties performed in England and Wales. 1 The reasons for this are unclear but may in part relate to the observation that the collection of PROMs data is currently only from NHSfunded operations, and that more UKRs than TKRs are privately funded and performed in non-NHS hospitals.
We are aware of only one other registry study comparing clinical outcomes of UKR and TKR. Lygre et al 23 interrogated the Norwegian registry and compared 372 UKRs and 972 TKRs at a mean of 6.5 years post-operatively. Their analysis included only post-operative knee injury and osteoarthritis outcome (KOOS) 24 and EQ-5D scores, and comparisons with pre-operative scores were not possible. Whereas some statistically significant differences were found between UKR and TKR for the KOOS subscales of symptoms, function in sport and recreation and function in daily living, these differences decreased with adjustment, and were below the accepted level for a minimal perceptible clinical difference in outcome. They therefore concluded that the two arthroplasties demonstrated similar levels of pain and function and questioned the use of UKR, given the reported higher rates of revision. 23 Both the NJR and the Swedish registry investigated patient satisfaction following knee arthroplasty. 25, 26 The Swedish study found no difference between the types of arthroplasty for general satisfaction, 25 whereas the NJR study found a higher level of satisfaction after TKR, despite the UKR group having a better post-operative OKS. 26 As in our study, Pearse et al 27 found in their analysis of the New Zealand registry that the unadjusted mean postoperative OKS was better for UKR (39.2) than for TKR (37.2), but they provided no further analysis nor attempted to account for the potential confounding factors. The clinical results of Newman, Pydisetty and Ackroyd 28 also confirmed that there are no significant differences in pain scores between TKR and UKR in the longer term. Pandit et al 5 reported on the first 1000 phase-3 Oxford UKRs from that centre. The mean OKS at five years was 41.3 (SD 7.2), compared with 24.7 (SD 8.7) pre-operatively, a mean rise of 16.6 points. These excellent results are superior to those in our registry study, where we found a mean unadjusted improvement in OKS of 13.9 for UKR, suggesting that the Oxford experience cannot be extrapolated nationally.
The final outcome of interest was the complication rate, which was high for both groups. This was probably due to the fact these were patients' reports rather than verified hospital data, and included complications such as allergy and urinary infection, which cannot be directly attributed to the arthroplasty and may be difficult for patients to define. Whereas there was no difference in the overall complication rates, there was variation between the types of arthroplasty in the rates of wound infection, readmission and reoperation.
Registry studies provide an assessment of current practice over a wide range of centres, surgeons and implants. Current registry data 1 report a significantly higher threeyear revision rate for UKR (7.2% (95% CI 6.6 to 7.9)) than for cemented TKR (2.1% (95% CI 2.0 to 2.2)), with the hazard ratio for revision being 2.5 and 3.7 for men and women, respectively. A recent comparison of the revision rates for the Oxford UKR reported from registries, independent centres, or the developing institution found a significantly lower revision rate for the developing institution (four times less) and independent centres (three times less) than joint registry papers. 29 This highlights the importance of publishing data from registries as a valid and realistic reflection of current practice.
In conclusion, using relevant risk adjustment we have shown no difference in improvement in either knee-specific or general health PROMs between UKR and TKR in a large cohort of registry patients. PROMs data are unique in reporting the patient's perception of outcome, and this should be of prime interest to surgeons. With concerns about the significantly higher revision rates for UKR observed in registries worldwide, we question the widespread use of an arthroplasty that does not confer a significant clinical benefit. There may, however, be justification for the use of such arthroplasties in specialist centres with published superior results.
